Home > Boards > US Listed > Biotechs > Vaxart, Inc. (VXRT)

I love the fundamentals on this speculative play...even

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
PennyWorld Member Profile
Member Level 
Followed By 35
Posts 6,426
Boards Moderated 0
Alias Born 04/25/02
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 5:02:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 4:35:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 4:35:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 4:35:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 4:34:25 PM
New Publication in Vaccine Highlights Preclinical Results of Vaxart’s Mucosal Chikungunya Vaccine Business Wire - 5/29/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2019 4:03:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 4:04:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 5:29:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 5:27:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 5:17:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 4:11:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 4:05:41 PM
Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update Business Wire - 5/9/2019 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/25/2019 2:28:55 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/24/2019 4:29:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2019 4:01:50 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/17/2019 11:13:51 AM
Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial Business Wire - 4/16/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 6:05:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 5:06:34 PM
Vaxart to Present at the 29th European Congress of Clinical Microbiology & Infectious Diseases Business Wire - 4/12/2019 8:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/12/2019 6:02:39 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 4/10/2019 5:09:18 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 4/10/2019 4:57:18 PM
PennyWorld Member Level  Thursday, 04/25/19 09:49:18 AM
Re: None
Post # of 535 
I love the fundamentals on this speculative play...even after the small new dilution (they do have to pay the bills). Very low O/S though. No risk of R/S anytime soon IMO. All it will take is a nice PR and we'll see a pop to 2 or 3 bucks. Have your email or text alerts turned on so you can take profits on a dime when that happens, because I suspect that the pop will be intra-day only. I am not giving investment advice!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist